Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma

Investigators from the National Institutes of Health report 2 partial responses in 3 peripheral T-cell lymphoma patients and 1 PR in 2 double-hit diffuse large b-cell lymphoma patients in ongoing...

Related Keywords

Germany ,Palo Alto ,California ,United States ,Joyce Lonergan ,Ahmed Hamdy ,Ian Flinn ,Gabriela Jairala ,Lifesci Advisors ,Exchange Commission ,Nasdaq ,National Institutes Of Health ,Globenewswire Inc ,Securities Exchange ,Vincerx Pharma Inc ,Chief Executive Officer ,Scientific Advisory Board ,Chief Scientific Officer ,Bone Oncology ,Versaptx Platform ,Securities Act ,Securities Exchange Act ,Sci Advisors ,